Blueberries Medical Corp.

BBM

CA09609Y1016

Drug Retailers

Market Closed - Canadian Securities Exchange Other stock markets 12:38:57 2024-06-28 EDT			5-day change	1st Jan Change
0.01 ^CAD	-50.00%		-50.00%	-50.00%

05-30	Blueberries Medical Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-26	Blueberries Medical Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Blueberries Medical Corp. Receives Approval from the Colombian Agricultural Institute for the Registration of Nine Psychoactive Tetrahydrocannabinol Dominant Strains

October 26, 2020 at 07:30 am

Blueberries Medical Corp. announced that the Company received approval from the Colombian Agricultural Institute for the registration of its nine psychoactive Tetrahydrocannabinol dominant strains with the national cultivar registry.

Latest news about Blueberries Medical Corp.

Blueberries Medical Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-30	CI
Blueberries Medical Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	04-26	CI
Blueberries Medical Corp. announced that it has received CAD 1.987876 million in funding	12-28	CI
Blueberries Medical Corp. announced that it expects to receive CAD 1.987876 million in funding	12-14	CI
Blueberries Medical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-24	CI
Blueberries Medical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-17	CI
Blueberries Medical Corp. Announces Board Changes	23-05-30	CI
Blueberries Medical Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-30	CI
Allied Corp. Signs Joint Venture with Blueberries Medical Corp. to Expand Product Offering and Bring Derivative Products to Global Markets	23-04-26	CI
Blueberries Medical Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-24	CI
Blueberries Medical Corp. Auditor Raises 'Going Concern' Doubt	23-04-23	CI
Blueberries Medical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-28	CI
Blueberries Medical Corp. announced that it has received CAD 1.47147 million in funding from Terraflos Inc.	22-11-27	CI
Blueberries Medical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-25	CI
Blueberries Medical Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-30	CI
Blueberries Medical Corp. Auditor Raises 'Going Concern' Doubt	22-05-02	CI
Blueberries Medical Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-05-02	CI
Blueberries Medical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-29	CI
Blueberries Medical Corp. Appoints Joaquin Barbera as New Independent Member of the Board of Directors	21-09-09	CI
Blueberries Medical Corp. announced that it has received CAD 1.901382 million in funding from Terraflos Inc.	21-09-08	CI
Blueberries Medical Corp. Announces Earnings Results for the Quarter and Six Months Ended June 30, 2021	21-08-30	CI
Blueberries Medical Corp. Announces Executive Changes	21-05-31	CI
Blueberries Medical Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-31	CI
Blueberries Medical Corp. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-30	CI
Blueberries Medical Corp. Auditor Raises 'Going Concern' Doubt	21-04-29	CI

Chart Blueberries Medical Corp.

Duration

Period

More charts

Company Profile

Blueberries Medical Corp. is a Canada-based company, which is a licensed producer of psychoactive and non-psychoactive cannabis by-products in Colombia. The Company is engaged in the growth, cultivation, and development of medicinal cannabis and related products with operations in Colombia. The Company is focused on processing and supplying medicinal-grade Cannabis oil extracts, medical flowers, and related products. It is developing and commercializing a range of cannabis-derived ingredients, including high and low tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoids. The Companyâs subsidiaries include Blueberries Research Corporation (BRC), Blueberries SAS (BBSAS), Centro De Desarrollo e Investigacion (CDIBBSAS), BBV Labs Inc. (BBV Labs.) and SATIN S.A.S. (SATIN). Blueberries SAS is a licensed producer and distributor of medicinal Cannabis and Cannabis-derived products in Colombia.

Sector

Drug Retailers

Calendar

2024-08-14 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Cannabis Product Retailers

	1st Jan change	Capi.
BLUEBERRIES MEDICAL CORP.	-50.00%	2.92M
GREEN THUMB INDUSTRIES INC.	+10.96%	2.86B
VERANO HOLDINGS CORP.	-16.50%	1.24B
GLASS HOUSE BRANDS INC.	+51.34%	517M
TERRASCEND CORP.	-15.45%	396M
HIGH TIDE INC.	+42.25%	178M
CANTOURAGE GROUP SE	-5.29%	90.86M
MARIMED INC.	-34.13%	68.84M
NOVA CANNABIS INC.	+44.94%	58.51M